201 related articles for article (PubMed ID: 33756436)
1. Associations between CYP3A4, CYP3A5 and SCN1A polymorphisms and carbamazepine metabolism in epilepsy: A meta-analysis.
Zhao GX; Zhang Z; Cai WK; Shen ML; Wang P; He GH
Epilepsy Res; 2021 Jul; 173():106615. PubMed ID: 33756436
[TBL] [Abstract][Full Text] [Related]
2. Association between SCN1A polymorphism and carbamazepine responsiveness in epilepsy: A meta-analysis.
Zhang X; Liu J; Ye J
Epilepsy Res; 2021 Oct; 176():106627. PubMed ID: 34218210
[TBL] [Abstract][Full Text] [Related]
3. ABCB1 c.3435C > T and EPHX1 c.416A > G polymorphisms influence plasma carbamazepine concentration, metabolism, and pharmacoresistance in epileptic patients.
Zhang ML; Chen XL; Bai ZF; Zhao X; Li WX; Wang XY; Zhang H; Chen XF; Zhang SQ; Tang JF; Xiao XH; Zhao YL
Gene; 2021 Dec; 805():145907. PubMed ID: 34411648
[TBL] [Abstract][Full Text] [Related]
4. Association of ABCB1 polymorphisms with carbamazepine metabolism and resistance in epilepsy: A meta-analysis.
Fan YX; Zhang Z; Meng JR; Yin SJ; Wang P; Zhou T; Huang YH; Meng R; He GH
Epilepsy Res; 2021 Nov; 177():106785. PubMed ID: 34653781
[TBL] [Abstract][Full Text] [Related]
5. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT
Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491
[TBL] [Abstract][Full Text] [Related]
6. Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy.
Yun W; Zhang F; Hu C; Luo X; Xue P; Wang J; Ge Y; Meng H; Guo Y
Epilepsy Res; 2013 Dec; 107(3):231-7. PubMed ID: 24125961
[TBL] [Abstract][Full Text] [Related]
7. Association between EPHX1 polymorphisms and carbamazepine metabolism in epilepsy: a meta-analysis.
Zhao GX; Shen ML; Zhang Z; Wang P; Xie CX; He GH
Int J Clin Pharm; 2019 Dec; 41(6):1414-1428. PubMed ID: 31650507
[TBL] [Abstract][Full Text] [Related]
8. Association of ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Chinese Han patients with epilepsy.
He XJ; Jian LY; He XL; Tang M; Wu Y; Xu YY; Sun XJ; Zhao LM
Epilepsia; 2014 Aug; 55(8):1301-6. PubMed ID: 24861996
[TBL] [Abstract][Full Text] [Related]
9. Association between two SCN1A polymorphisms and resistance to sodium channel blocking AEDs: a meta-analysis.
Bao Y; Liu X; Xiao Z
Neurol Sci; 2018 Jun; 39(6):1065-1072. PubMed ID: 29582177
[TBL] [Abstract][Full Text] [Related]
10. Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients.
Daci A; Beretta G; Vllasaliu D; Shala A; Govori V; Norata GD; Krasniqi S
PLoS One; 2015; 10(11):e0142408. PubMed ID: 26555147
[TBL] [Abstract][Full Text] [Related]
11. Effects of SCN1A and GABA receptor genetic polymorphisms on carbamazepine tolerability and efficacy in Chinese patients with partial seizures: 2-year longitudinal clinical follow-up.
Zhou BT; Zhou QH; Yin JY; Li GL; Qu J; Xu XJ; Liu D; Zhou HH; Liu ZQ
CNS Neurosci Ther; 2012 Jul; 18(7):566-72. PubMed ID: 22591328
[TBL] [Abstract][Full Text] [Related]
12. ABCG2, SCN1A and CYP3A5 genes polymorphism and drug-resistant epilepsy in children: A case-control study.
Mousavi SF; Hasanpour K; Nazarzadeh M; Adli A; Bazghandi MS; Asadi A; Rad A; Gholami O
Seizure; 2022 Apr; 97():58-62. PubMed ID: 35338956
[TBL] [Abstract][Full Text] [Related]
13. The potential implication of SCN1A and CYP3A5 genetic variants on antiepileptic drug resistance among Egyptian epileptic children.
Abo El Fotoh WM; Abd El Naby SA; Habib MS; ALrefai AA; Kasemy ZA
Seizure; 2016 Oct; 41():75-80. PubMed ID: 27498208
[TBL] [Abstract][Full Text] [Related]
14. [Association of single nucleotide polymorphisms of SCN1A gene with therapeutic effect of carbamazepine among ethnic Zhuang Chinese patients with epilepsy].
Huang J; Qian Z; Chen H; Huang Q; Huang L; Liu G; Tang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Mar; 36(3):271-274. PubMed ID: 30835363
[TBL] [Abstract][Full Text] [Related]
15. Association between two functional SNPs of SCN1A gene and efficacy of carbamazepine monotherapy for focal seizures in Chinese Han epileptic patients.
Wang P; Zhou Q; Sheng Y; Tang B; Liu Z; Zhou B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 May; 39(5):433-41. PubMed ID: 24921390
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of Carbamazepine: A Systematic Review on CYP3A4 and CYP3A5 Polymorphisms.
Riffi R; Boughrara W; Chentouf A; Ilias W; Taieb Ibrahim NM; Alioua Berrebbah A; Belhocine F
CNS Neurol Disord Drug Targets; 2024 Jun; ():. PubMed ID: 38859787
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of the association of SCN1A gene polymorphisms with the retention rate of carbamazepine following monotherapy for new-onset focal seizures in the Chinese Han population.
Zhou BT; Zhou QH; Yin JY; Li GL; Xu XJ; Qu J; Liu D; Zhou HH; Liu ZQ
Clin Exp Pharmacol Physiol; 2012 Apr; 39(4):379-84. PubMed ID: 22292851
[TBL] [Abstract][Full Text] [Related]
18. SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.
Shi L; Zhu M; Li H; Wen Z; Chen X; Luo J; Lin C; Zhang Z
Eur J Clin Pharmacol; 2019 May; 75(5):655-663. PubMed ID: 30693367
[TBL] [Abstract][Full Text] [Related]
19. SCN1AIVS5-91G>A polymorphism is associated with susceptibility to epilepsy but not with drug responsiveness.
Kumari R; Lakhan R; Kumar S; Garg RK; Misra UK; Kalita J; Mittal B
Biochimie; 2013 Jun; 95(6):1350-3. PubMed ID: 23466530
[TBL] [Abstract][Full Text] [Related]
20. SCN1A Polymorphisms and Haplotypes Are Associated With Valproic Acid Treatment Outcomes in Chinese Children With Epilepsy.
Zhu J; Lu J; Shen X; He Y; Xia H; Li W; Guo H; Zhang J; Fan X
Pediatr Neurol; 2023 Sep; 146():55-64. PubMed ID: 37451178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]